ArticleJournal of the National Cancer Institute2022

Real-World Use of Bone-Modifying Agents in Metastatic Castration-Sensitive Prostate Cancer.

Aaron P Mitchell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.